$1.61 Billion is the total value of Eventide Asset Management's 126 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 20.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BLUE | BLUEBIRD BIO INC | $59,847,000 | +15.6% | 569,700 | 0.0% | 3.73% | +8.7% | |
| XPO | Sell | XPO LOGISTICS INC | $57,133,000 | +5.6% | 884,000 | -21.8% | 3.56% | -0.7% |
| MIC | Buy | MACQUARIE INFRASTRUCTURE COR | $57,044,000 | -1.9% | 727,600 | +0.8% | 3.55% | -7.8% |
| LOW | LOWES COS INC | $43,804,000 | -5.7% | 565,000 | 0.0% | 2.73% | -11.3% | |
| W | Sell | WAYFAIR INCcl a | $43,437,000 | +53.5% | 565,000 | -19.2% | 2.70% | +44.3% |
| LOXO | Sell | LOXO ONCOLOGY INC | $42,501,000 | +74.4% | 530,000 | -8.5% | 2.65% | +64.0% |
| ABBV | Buy | ABBVIE INC | $40,424,000 | +11.7% | 557,500 | +0.4% | 2.52% | +5.1% |
| CELG | CELGENE CORP | $39,649,000 | +4.4% | 305,300 | 0.0% | 2.47% | -1.9% | |
| STKL | SUNOPTA INC | $39,647,000 | +46.8% | 3,887,000 | 0.0% | 2.47% | +38.0% | |
| STLD | STEEL DYNAMICS INC | $34,020,000 | +3.0% | 950,000 | 0.0% | 2.12% | -3.1% | |
| WBC | WABCO HLDGS INC | $32,592,000 | +8.6% | 255,600 | 0.0% | 2.03% | +2.1% | |
| LRCX | Sell | LAM RESEARCH CORP | $32,105,000 | -23.6% | 227,000 | -30.7% | 2.00% | -28.2% |
| CCI | Sell | CROWN CASTLE INTL CORP NEW | $30,805,000 | +5.8% | 307,500 | -0.3% | 1.92% | -0.5% |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $29,518,000 | +13.6% | 798,000 | +1.7% | 1.84% | +6.8% |
| SPLK | SPLUNK INC | $28,445,000 | -8.7% | 500,000 | 0.0% | 1.77% | -14.1% | |
| MGA | Buy | MAGNA INTL INC | $28,006,000 | +8.1% | 604,500 | +0.7% | 1.74% | +1.7% |
| AVXS | Buy | AVEXIS INC | $27,896,000 | +353.0% | 339,529 | +319.2% | 1.74% | +325.7% |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $27,617,000 | +27.5% | 2,207,610 | +2.5% | 1.72% | +19.9% |
| CYBR | CYBERARK SOFTWARE LTD | $27,473,000 | -1.8% | 550,000 | 0.0% | 1.71% | -7.7% | |
| SGEN | SEATTLE GENETICS INC | $27,164,000 | -17.7% | 525,000 | 0.0% | 1.69% | -22.6% | |
| WCN | Buy | WASTE CONNECTIONS INC | $27,056,000 | +75.2% | 420,000 | +140.0% | 1.68% | +64.8% |
| DOOR | Buy | MASONITE INTL CORP NEW | $26,425,000 | +7.6% | 350,000 | +12.9% | 1.64% | +1.2% |
| LEA | LEAR CORP | $26,143,000 | +0.4% | 184,000 | 0.0% | 1.63% | -5.6% | |
| ASML | ASML HOLDING N V | $26,062,000 | -1.9% | 200,000 | 0.0% | 1.62% | -7.7% | |
| SNA | SNAP ON INC | $25,280,000 | -6.3% | 160,000 | 0.0% | 1.57% | -11.9% | |
| TTD | New | THE TRADE DESK INC | $24,554,000 | – | 490,000 | +100.0% | 1.53% | – |
| KAR | Sell | KAR AUCTION SVCS INC | $24,217,000 | -38.4% | 577,000 | -35.9% | 1.51% | -42.0% |
| CRUS | CIRRUS LOGIC INC | $23,206,000 | +3.3% | 370,000 | 0.0% | 1.44% | -2.8% | |
| ARW | ARROW ELECTRS INC | $23,134,000 | +6.8% | 295,000 | 0.0% | 1.44% | +0.4% | |
| PFPT | Sell | PROOFPOINT INC | $23,010,000 | -3.3% | 265,000 | -17.2% | 1.43% | -9.0% |
| CAFD | Sell | 8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt | $22,258,000 | +10.9% | 1,471,100 | -0.6% | 1.39% | +4.3% |
| IDTI | Sell | INTEGRATED DEVICE TECHNOLOGY | $21,303,000 | -14.0% | 826,000 | -21.1% | 1.33% | -19.1% |
| AIMT | Buy | AIMMUNE THERAPEUTICS INC | $21,177,000 | +214.4% | 1,030,000 | +232.3% | 1.32% | +195.5% |
| PEGI | Sell | PATTERN ENERGY GROUP INCcl a | $21,122,000 | +17.9% | 886,000 | -0.4% | 1.32% | +10.9% |
| AY | Buy | ATLANTICA YIELD PLC | $20,377,000 | +5.3% | 954,000 | +3.4% | 1.27% | -0.9% |
| XLRN | ACCELERON PHARMA INC | $19,872,000 | +14.8% | 653,900 | 0.0% | 1.24% | +7.9% | |
| INST | INSTRUCTURE INC | $19,765,000 | +26.1% | 670,000 | 0.0% | 1.23% | +18.6% | |
| TWLO | TWILIO INCcl a | $19,358,000 | +0.8% | 665,000 | 0.0% | 1.20% | -5.2% | |
| IPHI | INPHI CORP | $19,037,000 | -29.7% | 555,000 | 0.0% | 1.18% | -33.9% | |
| FPRX | FIVE PRIME THERAPEUTICS INC | $18,096,000 | -16.7% | 601,000 | 0.0% | 1.13% | -21.6% | |
| VCYT | VERACYTE INC | $17,772,000 | -9.3% | 2,133,500 | 0.0% | 1.11% | -14.7% | |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $17,766,000 | +157.8% | 640,000 | +160.1% | 1.11% | +142.5% |
| HASI | Sell | HANNON ARMSTRONG SUST INFR C | $16,009,000 | +12.6% | 700,000 | -0.6% | 1.00% | +6.0% |
| AGIO | AGIOS PHARMACEUTICALS INC | $15,476,000 | -11.9% | 300,800 | 0.0% | 0.96% | -17.1% | |
| VMC | VULCAN MATLS CO | $13,935,000 | +5.1% | 110,000 | 0.0% | 0.87% | -1.0% | |
| 3106PS | New | DELPHI AUTOMOTIVE PLC | $13,849,000 | – | 158,000 | +100.0% | 0.86% | – |
| HUBS | New | HUBSPOT INC | $13,676,000 | – | 208,000 | +100.0% | 0.85% | – |
| BPMC | BLUEPRINT MEDICINES CORP | $13,428,000 | +26.7% | 265,000 | 0.0% | 0.84% | +19.1% | |
| TSLA | Sell | TESLA INC | $10,848,000 | -2.6% | 30,000 | -25.0% | 0.68% | -8.4% |
| STML | STEMLINE THERAPEUTICS INC | $9,995,000 | +7.6% | 1,086,400 | 0.0% | 0.62% | +1.1% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $9,335,000 | -18.9% | 334,700 | 0.0% | 0.58% | -23.8% | |
| ONCE | SPARK THERAPEUTICS INC | $8,961,000 | +12.0% | 150,000 | 0.0% | 0.56% | +5.3% | |
| KITE | Sell | KITE PHARMA INC | $8,812,000 | -12.3% | 85,000 | -33.6% | 0.55% | -17.4% |
| PANW | PALO ALTO NETWORKS INC | $8,698,000 | +18.8% | 65,000 | 0.0% | 0.54% | +11.8% | |
| WVE | WAVE LIFE SCIENCES LTD | $8,063,000 | -32.4% | 433,500 | 0.0% | 0.50% | -36.4% | |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $7,392,000 | -5.9% | 207,000 | -7.2% | 0.46% | -11.5% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $7,284,000 | -37.1% | 169,000 | -54.3% | 0.45% | -40.9% |
| XNCR | XENCOR INC | $7,262,000 | -11.7% | 344,000 | 0.0% | 0.45% | -17.1% | |
| CERN | CERNER CORP | $7,192,000 | +12.9% | 108,200 | 0.0% | 0.45% | +6.2% | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $7,178,000 | +55.6% | 90,000 | 0.0% | 0.45% | +46.6% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $6,812,000 | +3.5% | 75,000 | 0.0% | 0.42% | -2.8% | |
| PRTA | PROTHENA CORP PLC | $6,494,000 | -3.0% | 120,000 | 0.0% | 0.40% | -8.8% | |
| SAGE | SAGE THERAPEUTICS INC | $6,451,000 | +12.1% | 81,000 | 0.0% | 0.40% | +5.5% | |
| MYOV | Buy | MYOVANT SCIENCES LTD | $6,435,000 | +85.8% | 550,000 | +86.4% | 0.40% | +75.1% |
| EXR | EXTRA SPACE STORAGE INC | $6,357,000 | +4.8% | 81,500 | 0.0% | 0.40% | -1.2% | |
| GWPH | GW PHARMACEUTICALS PLCads | $6,366,000 | -17.1% | 63,500 | 0.0% | 0.40% | -22.0% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $5,750,000 | +6.2% | 125,000 | 0.0% | 0.36% | 0.0% | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $5,428,000 | -8.4% | 87,400 | 0.0% | 0.34% | -13.8% | |
| ATHN | Sell | ATHENAHEALTH INC | $5,200,000 | -9.9% | 37,000 | -27.7% | 0.32% | -15.2% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $5,197,000 | -14.5% | 190,000 | +15.2% | 0.32% | -19.6% |
| INCY | INCYTE CORP | $5,036,000 | -5.8% | 40,000 | 0.0% | 0.31% | -11.3% | |
| RGEN | REPLIGEN CORP | $4,558,000 | +17.7% | 110,000 | 0.0% | 0.28% | +10.9% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $4,459,000 | +17.8% | 34,600 | 0.0% | 0.28% | +10.8% | |
| ATRC | ATRICURE INC | $4,365,000 | +26.6% | 180,000 | 0.0% | 0.27% | +19.3% | |
| BOLD | AUDENTES THERAPEUTICS INC | $4,304,000 | +12.3% | 225,000 | 0.0% | 0.27% | +5.5% | |
| TTPH | TETRAPHASE PHARMACEUTICALS I | $4,278,000 | -22.4% | 600,000 | 0.0% | 0.27% | -27.1% | |
| EPZM | EPIZYME INC | $4,153,000 | -11.9% | 275,000 | 0.0% | 0.26% | -17.0% | |
| GLPG | GALAPAGOS NVspon adr | $3,979,000 | -11.2% | 52,000 | 0.0% | 0.25% | -16.5% | |
| ACHN | Buy | ACHILLION PHARMACEUTICALS IN | $3,902,000 | +54.5% | 850,000 | +41.7% | 0.24% | +45.5% |
| ACRS | ACLARIS THERAPEUTICS INC | $3,797,000 | -9.1% | 140,000 | 0.0% | 0.24% | -14.5% | |
| REGN | New | REGENERON PHARMACEUTICALS | $3,684,000 | – | 7,500 | +100.0% | 0.23% | – |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $3,625,000 | – | 192,000 | +100.0% | 0.23% | – |
| TSRO | TESARO INC | $3,636,000 | -9.1% | 26,000 | 0.0% | 0.23% | -14.7% | |
| DERM | New | DERMIRA INC | $3,613,000 | – | 124,000 | +100.0% | 0.22% | – |
| RXDX | New | IGNYTA INC | $3,560,000 | – | 344,000 | +100.0% | 0.22% | – |
| EXAS | New | EXACT SCIENCES CORP | $3,537,000 | – | 100,000 | +100.0% | 0.22% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $3,143,000 | – | 225,000 | +100.0% | 0.20% | – |
| NTUS | NATUS MEDICAL INC DEL | $2,798,000 | -5.0% | 75,000 | 0.0% | 0.17% | -10.8% | |
| VYGR | VOYAGER THERAPEUTICS INC | $2,688,000 | -32.3% | 300,000 | 0.0% | 0.17% | -36.5% | |
| MGNX | MACROGENICS INC | $2,574,000 | -5.9% | 147,000 | 0.0% | 0.16% | -11.6% | |
| AQXP | AQUINOX PHARMACEUTICALS INC | $2,462,000 | -15.7% | 175,000 | 0.0% | 0.15% | -20.7% | |
| SYRS | SYROS PHARMACEUTICALS INC | $2,414,000 | +1.0% | 150,000 | 0.0% | 0.15% | -5.1% | |
| CTMX | CYTOMX THERAPEUTICS INC | $2,325,000 | -10.3% | 150,000 | 0.0% | 0.14% | -15.7% | |
| SEP | Buy | SPECTRA ENERGY PARTNERS LP | $2,252,000 | +35.7% | 52,500 | +38.2% | 0.14% | +27.3% |
| TCON | TRACON PHARMACEUTICALS INC | $2,160,000 | -36.0% | 900,000 | 0.0% | 0.13% | -39.9% | |
| CHRS | COHERUS BIOSCIENCES INC | $2,081,000 | -32.1% | 145,000 | 0.0% | 0.13% | -36.0% | |
| CDTX | CIDARA THERAPEUTICS INC | $1,980,000 | -3.8% | 264,000 | 0.0% | 0.12% | -9.6% | |
| RARX | New | RA PHARMACEUTICALS INC | $1,874,000 | – | 100,000 | +100.0% | 0.12% | – |
| JCI | Buy | JOHNSON CTLS INTL PLC | $1,778,000 | +43.0% | 41,000 | +39.0% | 0.11% | +35.4% |
| ABB | Buy | ABB LTDsponsored adr | $1,693,000 | +43.2% | 68,000 | +34.7% | 0.10% | +34.6% |
| BCRX | New | BIOCRYST PHARMACEUTICALS | $1,612,000 | – | 290,000 | +100.0% | 0.10% | – |
| BEP | Buy | BROOKFIELD RENEWABLE PARTNERpartnership unit | $1,549,000 | +17.1% | 48,500 | +9.0% | 0.10% | +9.1% |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $1,414,000 | – | 125,000 | +100.0% | 0.09% | – |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $1,367,000 | +78.5% | 189,900 | +93.6% | 0.08% | +66.7% |
| TSM | Sell | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $1,363,000 | -3.5% | 39,000 | -9.3% | 0.08% | -8.6% |
| HMC | Buy | HONDA MOTOR LTD | $1,370,000 | +50.9% | 50,000 | +66.7% | 0.08% | +41.7% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $1,331,000 | – | 53,240 | +100.0% | 0.08% | – |
| HTGC | HERCULES CAPITAL INC | $1,324,000 | -12.5% | 100,000 | 0.0% | 0.08% | -18.0% | |
| ESSA PHARMA INC | $1,308,000 | -82.4% | 2,719,410 | 0.0% | 0.08% | -83.5% | ||
| FHB | Buy | FIRST HAWAIIAN INC | $1,286,000 | +79.1% | 42,000 | +75.0% | 0.08% | +66.7% |
| NYLD | Sell | NRG YIELD INCcl c | $1,214,000 | -2.0% | 69,000 | -1.4% | 0.08% | -7.3% |
| DRNA | DICERNA PHARMACEUTICALS INC | $1,195,000 | -6.8% | 377,000 | 0.0% | 0.07% | -12.9% | |
| BDN | Buy | BRANDYWINE RLTY TRsh ben int new | $1,183,000 | +20.5% | 67,500 | +11.6% | 0.07% | +13.8% |
| BG | Buy | BUNGE LIMITED | $1,007,000 | +49.4% | 13,500 | +58.8% | 0.06% | +40.0% |
| APU | New | AMERIGAS PARTNERS L Punit l p int | $903,000 | – | 20,000 | +100.0% | 0.06% | – |
| GLBL | Buy | TERRAFORM GLOBAL INCcl a | $808,000 | +34.7% | 160,000 | +28.0% | 0.05% | +25.0% |
| WBK | Buy | WESTPAC BKG CORPsponsored adr | $761,000 | +38.9% | 32,500 | +58.5% | 0.05% | +30.6% |
| ETN | Buy | EATON CORP PLC | $700,000 | +45.2% | 9,000 | +38.5% | 0.04% | +37.5% |
| ERIC | Buy | ERICSSONadr b sek 10 | $645,000 | +64.5% | 90,000 | +52.5% | 0.04% | +53.8% |
| TERP | Buy | TERRAFORM PWR INC | $516,000 | +279.4% | 43,000 | +290.9% | 0.03% | +255.6% |
| LXP | Buy | LEXINGTON REALTY TRUST | $496,000 | +29.2% | 50,000 | +29.9% | 0.03% | +24.0% |
| VTR | VENTAS INC | $486,000 | +6.8% | 7,000 | 0.0% | 0.03% | 0.0% | |
| LPT | LIBERTY PPTY TRsh ben int | $489,000 | +5.6% | 12,000 | 0.0% | 0.03% | -3.2% | |
| WELL | WELLTOWER INC | $412,000 | +5.6% | 5,500 | 0.0% | 0.03% | 0.0% | |
| AYI | Sell | ACUITY BRANDS INC | $407,000 | -98.0% | 2,000 | -98.0% | 0.02% | -98.2% |
| New | ACORDA THERAPEUTICS INCnote 1.750% 6/1 | $345,000 | – | 400,000 | +100.0% | 0.02% | – | |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS IN | $0 | – | -108,000 | -100.0% | -0.06% | – |
| AGTC | Exit | APPLIED GENETIC TECHNOL CORP | $0 | – | -184,100 | -100.0% | -0.08% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -306,200 | -100.0% | -0.10% | – |
| TIG | Exit | TIGENIXsponsored ads | $0 | – | -100,000 | -100.0% | -0.10% | – |
| BLCM | Exit | BELLICUM PHARMACEUTICALS INC | $0 | – | -130,000 | -100.0% | -0.11% | – |
| ALDR | Exit | ALDER BIOPHARMACEUTICALS INC | $0 | – | -79,000 | -100.0% | -0.11% | – |
| JUNO | Exit | JUNO THERAPEUTICS INC | $0 | – | -90,000 | -100.0% | -0.13% | – |
| AYR | Exit | AIRCASTLE LTD | $0 | – | -428,600 | -100.0% | -0.68% | – |
| WSO | Exit | WATSCO INC | $0 | – | -90,000 | -100.0% | -0.85% | – |
| ROL | Exit | ROLLINS INC | $0 | – | -590,000 | -100.0% | -1.45% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 43 | Q2 2024 | 3.2% |
| PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
| ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
| REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
| VERACYTE INC | 41 | Q2 2024 | 1.5% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
| COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
| BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
| Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
| Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
| Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
| Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
| Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
| Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-13 |
| SC 13G/A | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.